The Central Role of Cytochrome P450 Reductase (CPR) in Hyperoxic Lung Injury

被引:0
|
作者
Narke, Deven [1 ]
Moorthy, Bhagavatula [1 ]
机构
[1] Baylor Coll Med, Dept Pediat Newborn, Houston, TX 77030 USA
关键词
Acute respiratory distress syndrome; bronchopulmonary dysplasia; cytochrome P450 enzymes; cytochrome P450 reductase; hyperoxic lung injury; oxidative stress; reactive oxygen species; RESPIRATORY-DISTRESS-SYNDROME; VITAMIN-A SUPPLEMENTATION; BRONCHOPULMONARY DYSPLASIA; MURINE MODEL; PREVENTION; INFLAMMATION; EXPRESSION; ENZYMES; PATHOGENESIS; METABOLISM;
D O I
10.1080/17425255.2025.2470808
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
IntroductionHyperoxic lung injury results from excessive supplemental oxygen therapy in conditions such as bronchopulmonary dysplasia (BPD) in preterm infants and acute respiratory distress syndrome (ARDS) in adults. This review explores the role of cytochrome P450 reductase (CPR) in hyperoxic lung injury.Areas coveredHyperoxia induces the production of reactive oxygen species in excessive amounts, overwhelming the body's antioxidant defenses and exacerbating lung injury in ARDS/BPD. This review examines the differential roles of CPR-dependent enzymes in the context of hyperoxic lung injury. Additionally, we highlight the potential of targeting CPR to study mechanisms of lung injury and leverage gene-editing technologies to deepen our understanding of CPR-mediated pathways. This review consolidates existing knowledge on CPR-dependent processes and their roles in hyperoxic lung injury, based on a literature search conducted in the PubMed database for studies published between 1988 and 2024.Expert opinionThis review emphasizes the need for a deeper understanding of disease mechanisms, particularly CPR-mediated pathways. As a regulatory hub for ROS modulation and enzyme activity, CPR represents a promising target, offering a unified strategy to mitigate hyperoxic lung injury and improve outcomes in BPD/ARDS.
引用
收藏
页码:589 / 598
页数:10
相关论文
共 50 条
  • [31] Substrate promiscuity of cytochrome P450 RhF
    O'Reilly, Elaine
    Corbett, Mark
    Hussain, Shahed
    Kelly, Paul P.
    Richardson, Dominique
    Flitsch, Sabine L.
    Turner, Nicholas J.
    CATALYSIS SCIENCE & TECHNOLOGY, 2013, 3 (06) : 1490 - 1492
  • [32] Novel advances in cytochrome P450 research
    Singh, Deepika
    Kashyap, Akriti
    Pandey, Ram Vinay
    Saini, Kulvinder Singh
    DRUG DISCOVERY TODAY, 2011, 16 (17-18) : 793 - 799
  • [33] Cytochrome P450 Networks in Chemical Space
    Lee, Soyoung
    Kim, Dongsup
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (09) : 1361 - 1374
  • [34] Self-Sufficient Catalytic System of Human Cytochrome P450 4A11 and NADPH-P450 Reductase
    Han, Songhee
    Eun, Chang-Yong
    Han, Jung-Soo
    Chun, Young-Jin
    Kim, Dong-Hyun
    Yun, Chul-Ho
    Kim, Donghak
    BIOMOLECULES & THERAPEUTICS, 2009, 17 (02) : 156 - 161
  • [35] Loss of Endothelial Cytochrome P450 Reductase Induces Vascular Dysfunction in Mice
    Malacarne, Pedro Felipe
    Ratiu, Corina
    Gajos-Draus, Anna
    Mueller, Niklas
    Lopez, Melina
    Pflueger-Mueller, Beatrice
    Ding, Xinxin
    Warwick, Timothy
    Oo, James
    Siragusa, Mauro
    Angioni, Carlo
    Guenther, Stefan
    Weigert, Andreas
    Geisslinger, Gerd
    Luetjohann, Dieter
    Schunck, Wolf-Hagen
    Fleming, Ingrid
    Brandes, Ralf P.
    Rezende, Flavia
    HYPERTENSION, 2022, 79 (06) : 1216 - 1226
  • [36] Structure of the open conformation of a functional chimeric NADPH cytochrome P450 reductase
    Aigrain, Louise
    Pompon, Denis
    Morera, Solange
    Truan, Gilles
    EMBO REPORTS, 2009, 10 (07) : 742 - 747
  • [37] Mice lacking the Cytochrome P450 (CYP)1A2 Gene Display Increased Levels of F2-Isoprostanes, Oxidative DNA Adducts, and Hyperoxic Lung Injury In Vivo
    Moorthy, B.
    Wang, L.
    Couroucli, X., I
    Zhou, G-D
    Jiang, W.
    16TH INTERNATIONAL CONFERENCE ON CYTOCHROME P450, PROCEEDINGS, 2009, : 169 - 175
  • [38] Effects of transient overexpression or knockdown of cytochrome P450 reductase on reactive oxygen species generation and hypoxia reoxygenation injury in liver cells
    Pillai, Venkateswaran C.
    Snyder, Russell O.
    Gumaste, Upendra
    Thekkumkara, Thomas J.
    Mehvar, Reza
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (12): : 846 - 853
  • [39] CYTOCHROME P450 - ROLE IN DRUG METABOLISM AND GENETIC POLYMORPHISM
    Nandagopal, Anitha
    Unnisa, Syeda Viquar
    Shireen, Bushra
    Tasleem, Sheema
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (04): : 2979 - 2989
  • [40] Fluoxetine metabolism and pharmacological interactions: The role of cytochrome P450
    Mandrioli, R
    Forti, GC
    Raggi, MA
    CURRENT DRUG METABOLISM, 2006, 7 (02) : 127 - 133